生物技术进展 ›› 2020, Vol. 10 ›› Issue (3): 273-283.DOI: 10.19586/j.2095-2341.2019.0132

• 研究论文 • 上一篇    下一篇

KIF26B在非小细胞肺癌发生发展过程中的表达与功能研究

李芳芳,穆登彩,杨春艳,王磊,沈昊,郑尚永*   

  1. 云南大学医学院, 昆明 650091
  • 收稿日期:2019-12-26 出版日期:2020-05-25 发布日期:2020-02-21
  • 通讯作者: 郑尚永 E-mail: shangyong@ynu.edu.cn
  • 作者简介:李芳芳 E-mail: 1356693635@qq.com
  • 基金资助:
    国家自然科学基金项目(81860494)。

Expression and Function of KIF26B in the Development of Non-small Cell Lung Cancer

LI Fangfang, MU Dengcai,YANG Chunyan, WANG Lei, SHEN Hao, ZHENG Shangyong   

  1. School of Medicine, Yunnan University,  Kunming 650091, China
  • Received:2019-12-26 Online:2020-05-25 Published:2020-02-21

摘要: 驱动蛋白与肿瘤的发生有密切联系,但对 KIF26B驱动蛋白在非小细胞肺癌的表达和相关功能作用的研究甚少。为了探索KIF26B在非小细胞肺癌中的表达水平及潜在机制,通过干扰KIF26B后探索对非小细胞肺癌增殖、侵袭、迁移、细胞周期、凋亡以及相关蛋白表达量的影响。对mRNA TCGA 数据库信息分析得出,KIF26B基因在非小细胞肺癌中高表达。qRT-PCR 检测 KIF26B在几株常见非小细胞肺癌细胞系中的表达水平,筛选出 KIF26B在A549 和 NCI-H292细胞系中高表达。利用 RNA干扰技术(RNA interference, RNAi)敲低 A549 和 NCI-H292细胞的 KIF26B基因,通过CCK8、采用实时细胞分析仪、平板克隆及 Transwell 实验检测敲低 KIF26B基因后的生物学功能,免疫印迹法检测蛋白表达水平。结果显示,敲低KIF26B后A549 和 NCI-H292细胞增殖明显降低,侵袭及迁移能力明显减弱。敲低KIF26B后阻碍了A549 和 NCI-H292细胞从G1期向S期的转变,同时凋亡细胞明显增多,与之相关的细胞周期蛋白 D1、Bcl-2、E-cadherin和Vimentin的表达水平显著下调,同时活化的半胱天冬酶-3(active Caspase-3)和其剪切底物 PARP1 的剪切体(cleaved PARP1)表达水平显著上调。结果表明KIF26B可能作为非小细胞肺癌发生的促癌基因,参与了非小细胞肺癌的发生及发展过程。KIF26B有望成为非小细胞肺癌治疗的潜在靶点。

关键词: 非小细胞肺癌, KIF26B, 迁移, 侵袭, 凋亡, 周期

Abstract: Although kinesin is related to tumorigenesis closely, whether it is related to the expression and development of non-small lung cancer, and its specific biological effects and the molecular mechanisms have been few reported yet. After interfering with KIF26B, we explored the effects on proliferation, invasion, migration, cell cycle, apoptosis, and expression of related proteins in non-small cell lung cancer. By analyzing the mRNA TCGA database information, it was concluded that KIF26B gene is highly expressed in non-small cell lung cancer. Then the expression level of KIF26B in several common non-small cell lung cancer cell lines was detected by qRT-PCR, and KIF26B was screened for high expression in A549 and NCI-H292 cell lines. After using RNA interference (siRNA) to silence the KIF26B gene of A549 and NCI-H292 cells, the silenced KIF26B gene was detected by CCK8, real time cell analyzer (RTCA), plate cloning and Transwell experiments. Flow cytometry was used to analyze the effects of silenced KIF26B gene on cell cycle and apoptosis in NCI-H292 and A549, and Western blotting was used to detect the protein expression. The results showed that after silenced KIF26B, the proliferation of A549 and NCI-H292 cells was significantly reduced, and the ability to invade and migrate was significantly reduced. After silencing KIF26B, A549 and NCI-H292 cells were prevented from transforming from G1 to S phase, and apoptotic cells were significantly increased. Besides, the protein expression level of related cyclin D1, Bcl-2, E-cadherin and Vimentin reduced significantly, while activated Caspase-3 (active Caspase-3) and its cleavage substrate PARP1 (cleaved PARP1) expression levels were significantly up-regulated. The results indicated that KIF26B may be a tumor-promoting gene for non-small cell lung cancer, and it is involved in the occurrence and development of non-small cell lung cancer, KIF26B is expected  to be a potential target for the treatment of NSCLC.

Key words: non-small cell lung cancer(NSCLC), KIF26B, migration, invasion, apoptosis, cell cycle